TP53 and cancer: This is highly consistent with the study by Ziaran et al. [19], who examined p53, Ki-67, and E-cadherin in 224 patients and found that Ki-67 and E-cadherin were most strongly associated with cancer-specific survival, progression-free survival, and recurrence-free survival.